Action Point Financial Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Action Point Financial Planning's KNSA Position: Q3 2026 in Review
Action Point Financial Planning sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2026, closing a stake of 4 shares — an estimated $256 sold.
Action Point Financial Planning first reported a position in KNSA in Q2 2026 and held it in 1 quarter. The position peaked at $256 in Q2 2026. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Action Point Financial Planning reported no remaining Kiniksa Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 4 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $256.
- Action Point Financial Planning first reported a position in Kiniksa Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Kiniksa Pharmaceuticals position peaked at $256 in Q2 2026.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.